In Brief
A balance of excitatory and inhibitory signaling is critical for the coordinated functioning of neuronal circuits. Mende et al. (2016) demonstrate in a proprioceptive spinal reflex circuit how sensory neuron-derived retrograde signals locally regulate the potency of synapsing GABAergic inhibitory spinal interneurons.
SUMMARY
Circuit function in the CNS relies on the balanced interplay of excitatory and inhibitory synaptic signaling. How neuronal activity influences synaptic differentiation to maintain such balance remains unclear. In the mouse spinal cord, a population of GABAergic interneurons, GABApre, forms synapses with the terminals of proprioceptive sensory neurons and controls information transfer at sensory-motor connections through presynaptic inhibition. We show that reducing sensory glutamate release results in decreased expression of GABA-synthesizing enzymes GAD65 and GAD67 in GABApre terminals and decreased presynaptic inhibition. Glutamate directs GAD67 expression via the metabotropic glutamate receptor mGluR1b on GABApre terminals and regulates GAD65 expression via autocrine influence on sensory terminal BDNF. We demonstrate that dual retrograde signals from sensory terminals operate hierarchically to direct the molecular differentiation of GABApre terminals and the efficacy of presynaptic inhibition. These retrograde signals comprise a feedback mechanism by which excitatory sensory
INTRODUCTION
Synapses are key elements in the organization and function of neuronal circuits. The assembly of synapses is a progressive process that depends on the alignment and differentiation of pre-and postsynaptic structures. Initial synaptic associations involve surface recognition and adhesion, with acquired proximity permitting signals from the pre-and postsynaptic structures to induce specialized features of the complementary synaptic element (Akins and Biederer, 2006) . This general scheme is supported by molecular studies of vertebrate and invertebrate neuromuscular junctions (Fox et al., 2007; McCabe et al., 2003; Noakes et al., 1995) . Once synaptic structures are established, a process of highly dynamic communication between synaptic partners transmits neural information and maintains synaptic homeostasis. However, in the mammalian central nervous system (CNS), it remains unclear what retrograde molecular signals induce presynaptic differentiation and support homeostatic adaptations of synaptic function in local circuits.
Intrinsic neural activity and postsynaptic trophic signals have been implicated in the control of presynaptic differentiation (Andreae and Burrone, 2014) . Neuronal activity can act through cell-autonomous mechanisms to activate voltage-dependent Ca 2+ channels and downstream Ca 2+ -triggered signaling pathways (Greenberg et al., 1986) . Independently, activity-driven neurotransmitter release can act cell autonomously, signaling through autoreceptors, to influence presynaptic function (Bewick et al., 2005) , as well as nonautonomously, to influence the presynaptic differentiation of neighboring synapses via local diffusion (Kullmann and Asztely, 1998) . Neuronal activity also regulates expression of trophic factors important for synaptic development (Hong et al., 2008; Poo, 2001 ). However, how presumed homeostatic signals that influence presynaptic differentiation in the CNS converge to direct the complex and multifaceted biochemical differentiation of a single synaptic terminal remains unclear.
Many studies of synaptic differentiation have focused on inhibitory interneurons, given the biochemical and functional diversity of their neuronal subclasses (Ascoli et al., 2008) . At a functional level, inhibitory interneurons within the same microcircuit can exhibit distinct synaptic dynamics, reflecting the specialized character of different inhibitory terminals (Glickfeld and Scanziani, 2006) . Inhibitory synaptic terminals can also differ in their choice of neurotransmitter, predominantly GABA or glycine. Moreover, even within a single inhibitory neuronal class, multiple genes encoding different transmitter synthetic enzymes, synaptic vesicle proteins, and membrane channels can be expressed (Cauli et al., 1997; Lambolez et al., 1992; Monyer and Markram, 2004) . Different populations of GABAergic interneurons are characterized by expression of two GABA-synthesizing enzymes, glutamic acid decarboxylase-67 (GAD67) and glutamic acid decarboxylase-65 (GAD65) (Monyer and Markram, 2004; Soghomonian and Martin, 1998) . Both enzymes synthesize GABA and thus determine net neuronal GABA expression (Asada et al., 1997) . GAD67 is expressed in the cytosol of most GABAergic neurons and produces the majority of basal-level neurotransmitter released at GABAergic synapses (Asada et al., 1997) . In contrast, GAD65, which is expressed with GAD67 in a subset of GABAergic neurons, is vesicle bound and ensures GABA synthesis during prolonged synaptic transmission (Esclapez et al., 1994; Jin et al., 2003; Tian et al., 1999) . These different molecular characteristics permit individual terminals to respond to the physiological demands of their particular circuit.
In the spinal cord, GABApre neurons form highly specialized axo-axonic synapses with the terminals of primary sensory afferents, providing the anatomical substrate for presynaptic inhibition. GABApre neurons can be distinguished from other spinal inhibitory interneurons in that they coexpress GAD65 in conjunction with GAD67 (Betley et al., 2009; Hughes et al., 2005) . BDNF released by sensory terminals acts on GABApre terminals to promote synaptic terminal accumulation of GAD65 (Betley et al., 2009) . GAD67 levels are not affected in the absence of BDNF, suggesting that these two GABA synthetic enzymes are differentially regulated. More broadly, this distinction raises the possibility that multiple regulatory pathways act in parallel or hierarchically to influence the functional differentiation of GABApre presynaptic terminals.
Here we have explored the roles of activity-evoked transmitter release from sensory afferents in the differentiation and function of GABApre inhibitory terminals. We have used mouse molecular genetics to manipulate glutamate release from proprioceptive sensory terminals and glutamate receptor expression in GABApre neurons, examining the consequences of these manipulations on GAD enzyme expression by GABApre neurons and on presynaptic inhibition. Compromising glutamate release from sensory terminals by inactivating the predominant vesicular glutamate transporter vGluT1 elicits a marked reduction in GABApre GAD67 levels and functionally reduces the strength of presynaptic inhibition. Similarly, inactivating the mGluR1b receptor, which we show is expressed at GABApre terminals, reduces GAD67 expression and presynaptic inhibition. In addition, we find that depletion of glutamate release lowers spinal cord BDNF levels and GABApre terminal GAD65 levels, implying an upstream hierarchical role for activity-dependent glutamate release in coordinating both GABA synthetic enzymes. Together, these results indicate that distinct sensory-derived signals act together to determine the specialized presynaptic differentiation and function of a defined set of inhibitory interneurons in the mammalian CNS. Functionally, this constellation of signaling mechanisms supports a homeostatic feedback system by which sensory-derived glutamate controls GABA release from GABApre terminals to constrain activity across the sensory-motor synapse.
RESULTS

Decreased Glutamate Release from Proprioceptive Synapses Reduces Strength of Sensory-Motor Transmission
To assess the role of sensory-derived glutamate release in the differentiation and function of GABApre terminals, we used a mouse model in which the major vesicular glutamate transporter, vGluT1, utilized in proprioceptive synapses, was eliminated (Alvarez et al., 2004; Fremeau et al., 2004; Todd et al., 2003) . vGluT1 mutant mice survive for 3 weeks after birth and have compromised motor coordination, consistent with defects in sensorymotor transmission (Akay et al., 2014; Fremeau et al., 2004) . We confirmed complete absence of vGluT1 from proprioceptive terminals in postnatal day (p)12 and p21 vGluT1 mutant mice (Figures 1A-1C ; see Figures S1A, S1B, S1E-S1F 000 , S1K, and S1L available online). We further found that loss of vGluT1 did not lead to upregulation of the other two vesicular glutamate transporters, vGluT2 and vGluT3 ( Figures S1E-S1F 000 ; data not shown).
To measure the sensory-motor monosynaptic reflex in vGluT1 mutants, we employed a spinal cord in vitro preparation (Jiang et al., 1999; Mentis et al., 2005; Shneider et al., 2009) . In rodents, during the first 2 weeks after birth, proprioceptive synapses depress readily at frequencies as low as 1 Hz under in vitro conditions (Lev-Tov and Pinco, 1992; Li and Burke, 2001) . We therefore compared the efficacy of glutamate release in wild-type (WT) and vGluT1 mutant mice by measuring the amplitude of the ventral root reflex following successive dorsal root stimuli at 1Hz. We saw no difference in the amplitude of the monosynaptically mediated reflex between vGluT1 mutant and WT mice at the first trial; however, we noticed a significant reduction with successive trials of stimulation in vGluT1 mutants (Figure 1F) . The monosynaptic reflex recorded from WT mice was depressed by 45% at the second stimulus and reached its maximum depression ($60%) by the fifth stimulus, consistent with previous reports ( Figures 1E and 1F ) (Li and Burke, 2001) . In contrast, vGluT1 mutants revealed a more prominent reduction in synaptic depression compared to WT mice from the second trial ($70%), reaching a maximum level of depression ($90%) by the fifth trial ( Figures 1E and 1F ). These results demonstrate that glutamate neurotransmission in proprioceptive synapses is severely impaired in the absence of vGluT1.
The Effects of Glutamate Release on the Differentiation of GABApre Terminals
To test the role of glutamate release in the formation of GABApre-sensory contacts, we first assessed whether the differentiation of proprioceptive neurons and their synapses on motor neurons occurs normally in vGluT1 mutant mice. We found that dorsal root ganglia in vGluT1 mutants expressed normal numbers of Parvalbumin (Pv)
ON and Runt-related transcription factor 3 (Runx3)
ON sensory neurons ( Figure 1D ) (Chen et al., 2006; Inoue et al., 2002; Kramer et al., 2006; Levanon et al., 2002) . Also, Pv ON sensory terminals in vGluT1 mutants normally coexpressed the presynaptic marker SV2B (Grønborg et al., 2010) and aligned with the postsynaptic marker Shank1a (Figures 1A-1B 000 ; Figures S1K-S1N 00 ). Finally, analysis at the ultrastructural level revealed that proprioceptive terminals showed only a modest decrease in active zone (AZ) length ($17%; Figures S1G-S1I) and a similarly modest decrease in the density of synaptic vesicles near the AZ ($14%; Figures S1G, S1H, and S1J). Thus, the early differentiation of proprioceptive synapses appears relatively unaffected by loss of vGluT1.
We next examined whether the loss of vGluT1 from proprioceptive sensory terminals impacts the organization of GABApre terminals. We observed no change in number and size of GABApre contacts on sensory afferent terminals between WT and vGluT1 mutant mice (Figures S2F and S2G) . To analyze GABApre terminal differentiation, we analyzed expression of the GABA-synthetic enzymes GAD65 and GAD67 in p21 GABApre synaptic terminals (Betley et al., 2009 ). GAD67 expression levels were reduced by 52% in vGluT1 mutants as compared to WT mice (Figures 2A-2C ; for similar p12 values see Figures S2A-S2C ). To test the possibility that loss of vGluT1 affects GABApre terminal GAD67 expression by diminishing potential direct sensory input onto GABApre interneurons, we assessed GAD67 levels at terminals of GABApost interneurons, which form contacts directly on motor neurons and are known to receive direct sensory afferent input. We found that the level of GAD67 in GABApost terminals was not affected in vGluT1 mutants ( Figure 2C ), indicating that reduced glutamate release leads to a decrease in GAD67 expression specifically in GABApre terminals.
We next assessed whether GAD65 was also altered in GABApre terminals of vGluT1 mutant mice. vGluT1 mutant mice exhibited significantly reduced levels of GAD65 in GABApre terminals compared to WT mice (49% ; Figures 2A-2C ; for similar p12 values, see Figures S2A-S2C ). Since GAD65 is vesicle bound, we considered whether the reduction of GAD65 might be due to a reduced number of synaptic vesicles in vGluT1 
GFP; vGluT1
À/À mice ( Figure S2H ). This suggests that the observed decrease in the amount of GAD65 localized to the GABApre terminal is not due to a decrease in synaptic vesicle number. Taken together, the significant reduction in localization of the GABA-synthesizing enzymes to GABApre terminals seen in vGluT1 mutants suggests that compromised sensory-derived glutamate release affects the synaptic terminal differentiation of GABApre neurons.
Reduced Glutamate Release from Sensory Terminals Decreases the Strength of Presynaptic Inhibition
Given that GAD levels are reduced in GABApre terminals of vGluT1 mutant mice, we assessed whether loss of vGluT1 has a functional impact on presynaptic inhibition. We used an in vitro conditioning paradigm to measure the efficacy of presynaptic inhibition (see Supplemental Experimental Procedures for details). In this protocol, the amplitude of the monosynaptic reflex evoked by homonymous dorsal root stimulation was compared to that evoked by time-conditioned stimulation of the adjacent dorsal root (Figures 3A-3C ; Figures S3A-S3C). At long conditioning intervals (>300 ms), there was a gradual reduction of the monosynaptically evoked response, reaching statistical significance at conditioning intervals of 700-900 ms ( Figure 3D ; Figure S3D ). Blockade of GABA A receptors with bicuculline reversed this reduction, but application of strychnine, a glycine receptor blocker, did not (Figures 3E and 3F; Figures S3E and S3F) , suggesting that the conditioned reduction in monosynaptically evoked response was due to GABAergic presynaptic inhibition.
To assess presynaptic inhibition in vGluT1 mutant mice, we took advantage of the observation that with a single stimulus, the monosynaptically mediated reflex in vGluT1 mutant mice was comparable to that of WT mice (inset in Figure 3A ). The specific AMPA receptor blocker, NBQX, abolished this monosynaptic response (Figures S1C and S1D), confirming that neurotransmission at the proprioceptive synapses in vGluT1 mutant mice was glutamatergic in nature. We assessed the strength of presynaptic inhibition in vGluT1 mutant mice using the in vitro conditioning paradigm. In vGluT1 mutants, the strength of presynaptic inhibition was $50% reduced as compared to WT mice (WT, $35%; vGluT1 À/À , $18%; conditioning interval, 700-900 ms; Figures 3D-3F ). These results suggest that the reduction of GAD synthesizing enzymes seen in vGluT1 mutants has significant functional consequences for the strength of presynaptic inhibition.
Group I mGluR Expression in GABApre Terminals
We next examined whether glutamate influences the level of GAD65 and GAD67 in GABApre terminals. To assess whether glutamate might signal to GABApre terminals directly, we examined the expression of glutamate receptors on GABApre terminals. Presynaptic glutamate receptors have been shown to influence synaptic neurotransmitter release through a variety of mechanisms (Pinheiro and Mulle, 2008) . Unlike fast-acting ionotropic glutamate receptors, activation of metabotropic receptors (mGluRs) can last for long periods of time (Conn and Pin, 1997) . Since proprioceptive activity is relatively high even at quiescent periods (Prochazka, 1999) , we hypothesized that mGluRs are strong candidates to be acting as sensors for sustained glutamate release (Eccles et al., 1962) . To identify mGluR gene expression in postnatal spinal neurons, we carried out in situ hybridization analysis in p6 lumbar spinal cord, an age when GABApre neurons have formed clearly defined boutons on proprioceptive afferent terminals (Betley et al., 2009 ). Transcripts of group I, II, and III mGluR family members were expressed at detectable levels by various cells throughout the spinal cord (data not shown), consistent with previous reports (Alvarez et al., 2000; Berthele et al., 1999) . To test whether any of the mGluRs are expressed in GABApre neurons, we analyzed their expression immunochemically in Gad65-N45 GFP mice (Betley et al., 2009 ). We detected a group I mGluR, mGluR1b, in putative We next asked whether mGluR1b is localized to GABApre terminals. We used both light and EM immunocytochemistry to assess the expression of mGluR1b in N45 GFP ON GABApre terminals in the ventral spinal cord. Pre-embedding EM immunoperoxidase (ImP; N45 GFP) and immunogold (ImG; mGluR1b) cytochemistry (Pierce et al., 2009 ) revealed mGluR1b ImG particles predominantly associated with the plasma membrane of N45 GFP ON terminals ( Figures 4A-4D ). We observed mGluR1b
immunogold particles associated with synthetic pathway endomembranes in somata ( Figure S4B ), but did not observe mGluR1b expression at the plasma membranes of GABApre somata. We next quantified the extent of mGluR1b and N45 GFP coexpression by light microscopy using the endogenous expression of GAD67 and Synaptotagmin-1 (Syt1) as additional markers of GABApre terminals (Betley et al., 2009 Figures  S4C-S4C 000 ). This mosaic expression of mGluR1b is reminiscent of our previous finding that sensory terminals receive input from more than one GABApre neuron (Betley et al., 2009) and suggests that this group I metabotropic glutamate receptor is expressed presynaptically in a subset of GABApre neurons.
mGluR1 Directs GABApre Terminal Differentiation
To assess whether mGluR1b plays a role in GABApre terminal differentiation, we analyzed spinal cords of constitutive p21 mGluR1 knockout mice (Conquet et al., 1994) . mGluR1 mutants are severely ataxic, and both mGluR1a and mGluR1b are dysfunctional (Conquet et al., 1994) . We first addressed whether sensory-motor connectivity forms normally in these mice. We found no differences in the overall pattern of vGluT1 ON proprioceptive afferent terminals on motor neurons in mGluR1 mutant mice ( Figures 5A and 5B) . Furthermore, the synaptic density of proprioceptive afferent terminals contacting motor neuron cell bodies and proximal dendrites was unchanged compared to WT mice ( Figures S5A and S5B) . Finally, the percentage reduction of the sensory-motor reflex amplitude in mGluR1 mutant mice was largely similar compared to WT mice ( Figure S5C ). We next examined whether loss of mGluR1 affects differentiation of GABApre terminals. We found that expression of GAD67 was reduced by 21% with respect to WT controls (Figures 5C-5E ), but levels of GAD65 remained unchanged (Figures  5C-5E ; for similar p12 and p43 values, see Figure S5D ). The number and size of GABApre contacts was the same between WT and mGluR1 mutant mice, as was GABApre vesicle density ( Figure S2H ; data not shown). Loss of mGluR1 did not result in any significant differences in vGluT1 fluorescent intensity in proprioceptive terminals, or GAD67 in premotor GABApost terminals ( Figure 5F ). These results provide strong evidence that GAD67 is specifically reduced in GABApre terminals in mGluR1 mutant mice.
Loss of mGluR1 Decreases the Strength of Presynaptic Inhibition
We next examined whether the specific decrease in GAD67 levels seen in mGluR1 mutant mice also correlated with deficits in presynaptic inhibition. We measured the strength of presynaptic inhibition in mGluR1 mutant mice and found that it was reduced by 50% compared to WT counterparts (WT, $34%; mGluR1
, $16%; conditioning interval, 700-900 ms; Figures  6A-6C ). These results affirm that compromised sensory-derived glutamate signaling to GABApre terminals has a functional consequence on the efficacy of presynaptic inhibition. Given that GAD67, but not GAD65, is reduced in mGluR1 mutants, the observed deficit further suggests that GAD67 plays a more prominent role than GAD65 in mediating presynaptic inhibition.
To further explore the function of presynaptic mGluR1b, we measured presynaptic inhibition physiologically in WT mice, using the in vitro spinal cord preparation, following bath application of the mGluR1 antagonist CPCCOEt (Bonnot et al., 2009 ). There was a trend toward a reduction in presynaptic inhibition, which did not reach statistical significance ( Figure 6D) , suggesting that the effect of pharmacological block of mGluR1 signaling on GAD67 requires longer duration exposure.
Glutamate Release Controls Expression of BDNF While GAD67 levels in GABApre terminals depend on glutamate signaling via mGluR1, the lack of change in GAD65 expression in mGluR1 mutants-despite its reduction in vGluT1 mutantssuggests an alternative mechanism of glutamate-dependent regulation. The localization of GAD65 in GABApre terminals is dependent on retrograde BDNF emanating from sensory terminals (Betley et al., 2009 ). Since GAD65 levels are reduced in vGluT1 mutants, we assessed the expression level of BDNF in vGluT1 mutant spinal cords. We found that BDNF protein levels were $50% reduced in vGluT1 mutant spinal cords compared to WT mice ( Figure 7A ). In comparison, BDNF levels were not significantly decreased in mGluR1 mutant spinal cords ( Figure 7B ).
To assess whether the GAD65 phenotype in vGluT1 mutant mice might be mediated by a reduction in sensory BDNF release, we studied the overexpression of BDNF in the spinal cord in vivo. To do so, we used a recombinant adeno-associated virus (AAV2/9) vector encoding mBDNF under the CMV promoter (AAV2/9-CMV-GFP-BDNF). The virus was delivered by an GFP immunoperoxidase ( N45 GFP-ImP; gray immunoreactivity) and mGluR1b immunogold (mGluR1b-ImG; gold particle) double-labeled in GABApre presynaptic terminals (p). mGluR1b ImG particle (red arrowhead) is membrane associated and in close proximity to sensory afferent terminals (st) on p21 motor neuron dendrites (de) Figures 7C-7F 000 ; data not shown). Following injection of AAV-GFP-BDNF, levels of BDNF in the DRG of vGluT1 mutant mice were elevated $5-fold compared to endogenous WT levels ( Figure S6A ). We next examined whether elevating BDNF levels in vGluT1 mutant mice affects the differentiation of GABApre terminals. Assessing GAD65 expression in GABApre terminals synapsing upon transfected GFP-BDNF expressing sensory terminals revealed a rescue of GAD65 expression to WT levels, while GAD67 levels remained low (Figures 7G-7P ). Since viral transfection was incomplete, we assessed whether mosaic restoration of sensory terminal BDNF expression rescued GABApre GAD65 broadly throughout the animal or only in local circuits. Analysis of GABApre boutons synapsing on nontransfected Figure 7K ). These data strongly support a direct, local-circuit effect of sensory terminal BDNF on GABApre terminal GAD65 expression and thus suggest against diffuse or indirect impact of BDNF on GABApre differentiation. Our mGluR1 mutant analysis suggests that GAD67 is the major GAD isoform controlling presynaptic inhibition. To assess the contribution of GAD65 to presynaptic inhibition, we next disrupted BDNF signaling. Sensory-derived BDNF signals via GABApre-localized TrkB receptor induce the synaptic localization of GAD65 (Betley et al., 2009 ). We measured presynaptic inhibition in mice in which we conditionally deleted TrkB from GABApre neurons. To do so, we intercrossed a Ptf1a
Cre mouse line, which directs Cre expression to GABAergic interneurons (Betley et al., 2009; Glasgow et al., 2005; Kawaguchi et al., 2002) , with a conditional TrkB flox/flox mouse line (He et al., 2004) Figure 7Q ). This result is consistent with a primary role for GAD67 in determining the efficacy of GABApre-mediated presynaptic inhibition. Taken together, our results support a mechanism whereby proprioceptive sensory-derived glutamate and BDNF collaborate in a hierarchical manner to control the presynaptic differentiation of GABApre terminals and the efficacy of presynaptic inhibition ( Figure 7R ).
DISCUSSION
The inhibitory gating of sensory-motor neurotransmission in the spinal cord is mediated by a specialized set of GABApre interneurons that form contacts directly with sensory terminals. In this study we have explored how distinct retrograde signalsmediated by an excitatory transmitter and a trophic peptideact together to regulate the specialized features of presynaptic differentiation with consequence for inhibitory gating. Our findings reveal that glutamate release from sensory terminals acts via a metabotropic glutamate receptor expressed on GABApre terminals to control both the expression of GAD67 and the efficacy of presynaptic inhibition. Our results further suggest that glutamate release controls the expression of GAD65 in GABApre terminals indirectly via an autocrine influence on sensory BDNF expression.
Retrograde Signaling and the Regulation of GAD Isoforms
Physiological and genetic studies of GAD67 expression in the CNS suggest strongly that GAD67 mRNA and protein are increased in response to neuronal activity (Esclapez and Houser, 1999; Lau and Murthy, 2012; Liang et al., 1996; Ramírez and Gutié rrez, 2001 ). In contrast, GAD65 levels in GABApre terminals are controlled via protein trafficking in response to retrograde sensory-derived BDNF signaling via TrkB receptors (Betley et al., 2009) . Whether the decrease in GAD67 we observe when sensory glutamate signaling is impaired reflects deficits in new mRNA or protein synthesis or altered trafficking of existing protein will require further study. We have performed Gad65 and Gad67 in situ hybridization on vGluT1 mutant and WT spinal cords and observe no qualitative differences ( Figures S2D-S2E  0 ) . The decrease in GAD67 in the absence of mGluR1 would be consistent with the longstanding model that group I metabotropic glutamate receptor signaling leads to protein synthesis (Weiler and Greenough, 1993) . Studies of long-term synaptic depression (LTD) and Fragile X syndrome have implicated group I metabotropic glutamate receptors mGluR1 and mGluR5 in directing local translation of synaptic mRNA (Krueger and Bear, 2011) . Furthermore, published PAR-CLIP analysis suggests that the transcript encoding GAD67, but not GAD65, binds the Fragile X mental retardation associated RNA binding protein FMRP (Ascano et al., 2012) , suggesting local translation as a possible means by which GABApre terminal GAD67 levels are controlled. The decrease in GAD67 we observe in the absence of mGluR1 indicates that sensory-derived glutamate acts directly on GABApre terminals to influence GAD67 levels. However, the incomplete replication of the vGluT1 phenotype in mGluR1 mutants is consistent with our observation that mGluR1b expression defines only a subset of GABApre neurons. This raises the possibility that other mGluRs might be involved in directing GAD67 expression in GABApre terminals or that other changes in GABAergic signaling machinery may contribute to the observed effects of vGluT1 or mGluR1 mutation on presynaptic inhibition. In line with this possibility, we detect RNA expression of mGluR5 in the dorsal intermediate region of spinal cord in which GABApre cell bodies are found (data not shown). Attempts to explore genetic interaction between combined mutations of vGluT1 and mGluR1 were not possible due to embryonic lethality of double mutant mice (data not shown).
How Do Retrograde Signals Collaborate to Control Presynaptic Differentiation?
Given the specific architecture of the presynaptic inhibitory microcircuit, in which GABApre terminals directly contact sensory afferent terminals, sensory-derived signals are well positioned to regulate the presynaptic differentiation of associated GABApre boutons. In this work we implicate both sensory derived BDNF and glutamate as signals directing presynaptic differentiation, yet we also suggest these operate in a hierarchical manner, with alterations in glutamate release influencing expression of BDNF. BDNF expression is known to be activity dependent with transcription regulated by membrane depolarization and signaling downstream of calcium influx (Hong et al., 2008; West et al., 2002) . Glutamate release from synaptic-like vesicles at the peripheral mechano-sensory endings of sensory afferents has been suggested to act in an autocrine fashion to enhance terminal excitability during sustained stretch, via an atypical phospholipase-D coupled glutamate receptor (Bewick et al., 2005) . We propose a similar mechanism at central sensory afferent terminals whereby sensory afferent glutamate release acts cell-autonomously to regulate BDNF expression ( Figure 7R ). The reported expression of mGluR receptors at central sensory terminals would lend credence to such a model (Ohishi et al., 1995) , supporting a local control mechanism at sensory afferent terminals. An alternative possibility is that the decrease in BDNF expression in the CNS resulting from vGluT1 mutation might reflect impaired autocrine glutamate signaling from synapticlike vesicles in the periphery. If peripheral autocrine glutamate signaling increases terminal excitability in response to stretch, then vGluT1 mutation could decrease overall sensory afferent activity and thereby decrease central terminal BDNF expression.
Regardless of the precise mechanism, our results support a model in which glutamate and BDNF act as trans-synaptic retrograde signals in parallel, but also hierarchically, with autocrine glutamate signaling regulating sensory afferent BDNF expression. They further provide a functional context for understanding how activity-dependent regulation of BDNF may ''fine-tune'' synaptic differentiation in a neuronal microcircuit. Indeed, that the retrograde signaling mechanism we describe functions locally to fine-tune individual circuits is supported by our finding that virally mediated mosaic increase in sensory BDNF expression in a vGluT1 mutant background leads to tightly correlated mosaic rescue of GABApre terminal GAD65 levels.
Implications of Functional Presynaptic Inhibition for Local Circuit Feedback
Presynaptic mGluRs have previously been suggested to play a role in feedforward amplification of excitatory signals (Mitchell and Silver, 2000; Semyanov and Kullmann, 2000) . Here we demonstrate a novel presynaptic function for an mGluR class I receptor and describe a circuit arrangement in which presynaptic mGluR functions in a feedback manner to modulate GABAergic inhibition of a proximate sensory afferent glutamate source. This scaling of GABA release would allow for the strength of transmission across the sensory-motor connection to be held constant even when activity levels of the incoming proprioceptive sensory afferent are altered, reflected in changes of vGluT1 expression ( Figure 7R ). Fink and colleagues (Fink et al., 2014) recently described features of the GABApre interneuron population responsible for scaling presynaptic inhibition to widely variable frequency and intensity of sensory afferent activity during movement: these include high-frequency firing in response to proprioceptive input, and the selective expression of GAD65. Our work describes a novel and distinct, but complementary, means by which GABApre inhibition is scaled to match sensory afferent output, over a time course involving modulation of synaptic protein levels and in a manner that supports homeostatic ''self-tuning'' of circuit excitability (Turrigiano and Nelson, 2004) . The decrease in presynaptic inhibition we observe in the absence of mGluR1 appears to reflect alterations in the level of GAD67, rather than GAD65. The predominant role of GAD67 is further supported by our observation that disrupting BDNF signaling via targeted TrkB deletion, which prevents GABApre-terminal accumulation of GAD65, has limited impact on measured presynaptic inhibition. The coexpression of GAD67 and GAD65 in GABApre neurons thus may support the interneurons' capacity to scale inhibition to meet sensory afferent demands dynamically both in the immediate temporal context of a particular behavior but also over a more extended period of adaptive development. The observation that both the 21% decrease in GABApre terminal GAD67 seen in mGluR1 mutants and the 50% decrease seen in vGluT1 mutants lead to similar decrements in measured presynaptic inhibition suggests that the relationship between visualized GAD67 level and presynaptic inhibitory strength is nonlinear, and that the reduction in presynaptic inhibition may be maximal in mGluR1 mutants. This nonlinearity may reflect the kinetics of GAD67 activity and its relationship to inhibitory function, or it may reflect other, unknown mechanisms of compensation to loss of mGluR1 and/or vGluT1.
In essence, our findings support a model whereby the inhibitory potency of GABAergic interneurons is increased in response to excitatory activity, such that a homeostatic balance of excitation and inhibition is maintained. Deficits in such homeostatic regulation of network activity have been proposed to underlie numerous mental retardation and autistic spectrum disorders (Ramocki and Zoghbi, 2008) . Our experiments emphasize the function of GAD67 in homeostatic adaptation of GABApre interneurons to sensory activity, which is congruent with GAD67's role as the predominant form of the GABA synthesizing enzymes in the CNS. Our model may be specifically relevant to the pathophysiology of schizophrenia, bipolar disorder and epilepsy, in which altered GAD67 levels have been observed (Akbarian et al., 1995; Heckers et al., 2002; Lewis et al., 2005) . More broadly, the model we present in which hierarchically organized retrograde signals direct the distinct molecular differentiation of a GABAergic terminal, provides insights into the adaptive mechanisms by which neuronal circuits maintain an appropriate balance of excitation and inhibition.
EXPERIMENTAL PROCEDURES Mouse Strains
The following mouse strains were used in this study: Gad65-N45 GFP (LopezBendito et al., 2004) , mGluR1 (Conquet et al., 1994) , Ptf1a
Cre , TrkB flox/flox (He et al., 2004) , and vGluT1 ( Slc17a7 tm1Edw ) (Fremeau et al., 2004) . mGluR1 genotyping information is provided in Supplemental Experimental Procedures. Both male and female mice were used. All procedures were carried out in accordance with Memorial Sloan Kettering and Columbia University IACUC guidelines.
Immunohistochemistry
Antibodies are listed in Supplemental Experimental Procedures. Immunohistochemistry was performed either on 12 mm cryostat sections or 75 mm Vibratome sections (depending on the experimental paradigm) of L4-L5 spinal segments using primary and fluorophore-conjugated secondary antibodies (Jackson Labs) as previously described (Betley et al., 2009) .
Histochemistry
Probe information is listed in Supplemental Experimental Procedures. In situ hybridization was performed on 12 mm cryostat sections as described previously (Arber et al., 2000; Betley et al., 2009 ).
Labeling of Sensory-Motor Connections CTb Labeling
Motor neurons and proprioceptive sensory afferent projections of the Gastrocnemius muscle were labeled by intramuscular injection of 2 ml 1% Alexa 488 -conjugated attenuated cholera toxin b subunit (CTb; Invitrogen; Shneider et al., 2009) . Injections were carried out on WT and vGluT1 mutant mice at p8 and p12 (n R 3 for each genotype and developmental time point), and spinal cords were harvested at p12 and p21, respectively. CTb staining was enhanced with anti-CTb antibody, 1:1,000 (List Biological Laboratories Inc. (0-50 and 50-100 mm dendritic segments from the soma) on confocal images in the z axis. A Leica SP5 confocal microscope equipped with four single laser lines was used. Analysis was performed with the Leica software (LAS AF) as we described in detail in Mentis et al. (2011) .
Synaptic Measurements Density Measurements
Images were acquired on a Leica SP5 confocal microscope and analyzed off-line. The number of Pv ON synapses contacting motor neuron cell bodies was counted using LAS AF software.
Staining Intensity Measurements
Images of synaptic terminals were acquired on a Leica SP5 confocal microscope using either a 403 objective with 33 digital zoom or a 1003 objective with 43 digital zoom at 1,024 3 1,024 optical resolution. Images from WT (R) The model proposed for regulation of presynaptic inhibition, whereby glutamate (red) release at sensory terminals controls GAD65 and GAD67 levels in GABApre terminals via two distinct pathways. Glutamate controls the level of GAD67 (red) directly via mGluR1b on GABApre terminals. Glutamate also regulates in an autocrine manner sensory terminal expression of BDNF (green), which acts via TrkB receptors on GABApre terminals to control presynaptic levels of GAD65 (green). Consequently, in vGluT1 À/À mice, reduced glutamate release from proprioceptive afferent terminals leads to decreased levels of both GAD65 and GAD67. In mGluR1 À/À spinal cords, GABApre synapses are impaired in sensing glutamate release, resulting in reduced levels of GAD67 expression, while GAD65 levels remain normal. Scale bars, 50 mm (C), 20 mm (D), 2 mm (E-J 0 and L-O 0 ). Lines and whiskers on box diagrams represent data between 9th and 91st percentile, dots show the 5th and 95th percentile. Error bars represent SEM. See also Figure S6 .
and mutant mice were acquired using identical microscope settings for excitation and fluorescence detection parameters. Further details on density and staining intensity measurements are provided in Supplemental Experimental Procedures.
EM Immunohistochemistry and Analysis
All mice were anaesthetized with sodium pentobarbital (150 mg/kg i.p.) and sequentially perfused transcardially and sequentially with 2% heparin-saline, 3.75% acrolein and 2% paraformaldehyde (PFA) in phosphate buffer (PB). Spinal cords were extracted by ventral laminectomy and postfixed for 30 min in 2% PFA. 40 mm vibratome sections of L4-L5 spinal cords from CTb-injected mice (p12 or p21) or from Gad65-N45 GFP mice (p21) were processed for pre-embedding EM single or dual immunolabeling, respectively, and examined ultrastructurally (Pierce et al., 2009 ). Further information is provided in Supplemental Experimental Procedures.
Electrophysiology
Detailed methods have been previously described (Mentis et al., 2005; Shneider et al., 2009) and are outlined in Supplemental Experimental Procedures.
BNDF ELISA
Mature BDNF (mBDNF) protein levels were quantified using the BDNF E max ImmunoAssay System kit (catalog # G7611; Promega, Madison, WI, USA) with recombinant mBDNF as a standard (Kabir et al., 2012) . Protein was extracted and quantitated following the manufacturer's protocol. Further technical details are provided in Supplemental Experimental Procedures.
Real-Time RT-PCR
Total RNA was extracted from frozen DRG tissue using the mirVana miRNA isolation kit (Ambion, Foster City, CA). cDNA was synthesized by reverse transcription of total RNA using the High Capacity RNA-to-cDNA kit (Applied Biosystems, Foster City, CA). The relative amount of bdnf exon IX transcript present in the sample was measured by quantitative real-time PCR using SYBR Green detection (Applied Biosystems, Foster City, CA) following parameters as in Schierberl et al. (2011) . All samples were measured in triplicates and mRNA levels were normalized to GAPDH mRNA levels. Primer information is provided in Supplemental Experimental Procedures.
AAV Experiment
Wt or vGluT1 mutant mice were anaesthetized by isoflurane (by inhalation) and injected intracerebroventricularly (ICV) with 2 ml of 2.3 3 10 12 GC/ml AAV2/9-CMV-GFP virus (Vector BioLabs) or 10 ml of 7.5 3 10 13 GC/ml AAV2/9-CMV-GFP-2A-mBDNF virus (Vector BioLabs) at p1, using a modified Hamilton syringe (Robbins et al., 2014) . Pups were allowed to recover from anesthesia for 30 min before returned to the cage. Mice were sacrificed at p19 and spinal cord was harvested following transcardial perfusion with 4% paraformaldehyde.
Statistics
Staining Intensity Measurements
For each experimental condition >100 synapses from R3 mice were analyzed. Staining intensity measurements were normalized with respect to dataset from control tissue. All values reported are mean ± SEM. Statistical differences were established by Student's t test or ANOVA. If a dataset failed normal distribution (assessed through Shapiro-Wilk test) statistical differences were determined by MannWhitney rank sum test. The level of statistical significance was assigned as *p % 0.05, **p % 0.01, and ***p % 0.001. NS signifies not significant. Box diagrams include data points between lower and upper quartile, with the line representing the median value. Lines and whiskers represent data between 9th and 91st percentile; dots show the 5th and 95th percentile.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article at http://dx.doi.org/10.1016/j. neuron.2016.05.008.
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